Medscape

Medscape InDiscussion: Myasthenia Gravis

Science EN ↓ 6 avsnitt

Listen to Medscape InDiscussion: Myasthenia Gravis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989800). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Glöm inte att besöka poddens webbplats och stötta skaparen: www.medscape.com

Skapare

Medscape

Kategori

Science

Poddens webbplats

www.medscape.com

Senaste avsnittet

24 okt 2023

Var kan du lyssna?

Poddar i appen Replaio Radio Kommer snart

Poddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar

Ladda ned på Google Play Installera gratis Android nästan 10 mn nedladdningar · betyg 4,7+ iOS snart

Avsnitt

Managing Myasthenia Gravis in Primary Care: Best Practices 24.10.2023

Drs Nicholas Silvestri and Michael Hehir discuss best practices for primary care physicians who see patients with myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990463). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare profe...

Myasthenia Gravis: Exercise and Lifestyle Considerations 21.09.2023

Drs Nicholas Silvestri and Kelly Gwathmey discuss how exercise and other modifiable lifestyle factors can influence how patients experience the burden of myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990462). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast...

Myasthenia Gravis: Who Really Benefits From Thymectomy? 23.08.2023

Drs Nicholas Silvestri and Gil Wolfe get right to the point about when and why thymectomy may be considered as an evidence-based option for treatment of myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990461). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast i...

Tools for More Personalized Myasthenia Gravis Care 25.07.2023

Drs Nicholas Silvestri and James "Chip" Howard discuss newer and novel myasthenia gravis tools to personalize treatment, including complement inhibitors, FcRn antagonists, biomarkers, and more. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990460). The topics and discussions are planned, produced, and reviewed independently of adver...

Treating Myasthenia Gravis? Don't Stop at Pyridostigmine 22.06.2023

Drs Nicholas Silvestri and Neelam Goyal lay out pathways for successful routine treatment of myasthenia gravis. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/990458). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources A...

Myasthenia Gravis: Which Test Is Best? When and Why? 22.06.2023

Drs Nicholas Silvestri and Carolina Barnett-Tapia discuss what you need to know about immunopathogenesis and diagnosis for this relatively rare condition. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989800). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only f...

Lyssna på podden Medscape InDiscussion: Myasthenia Gravis i Replaio

Radio och poddar i en och samma app - gratis och utan konto. Installera redan idag och missa inte premiären

Ladda ned på Google Play

Replaio är ingen poddutgivare; programnamn, omslag och ljud tillhör sina upphovspersoner och distribueras via offentliga RSS-flöden